Transaction · 0002048497-26-000018

Hopman Mark

Hopman Mark, CCO, reported an open-market or private sale at Beta Bionics, Inc. involving 370.000000 shares for an estimated $7015.20. Reported holdings after the transaction were 56109.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SCCO
BBNXBeta Bionics, Inc.
Filing timeOct 05
Trade dateOct 01, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position traded0.66%Shares sold ÷ (holdings after + shares sold). Estimated position before: 56,479 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$18.95
Pre-filing
1mo ago +0.6%1w ago +14.8%1d ago +0.2%
Returns since
7d30d90d180d1y

BBNX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
BBNX since 2026-10-05Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0002048497-26-000018
Common Stock
Transaction date
Oct 01, 2026
Filed Oct 05, 2026, 09:11 PM · 4d delay
Shares
370 sh
$18.96 per share
Estimated value
-$7.01k
Computed from shares × price
Holdings after
56.1k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Selling Direct Ownership Repeat Seller 10b5-1 Detected
-4score
Filing-only score

-4

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Commercial Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on June 10, 2026.

  2. F2

    The weighted average sale price for the transaction reported was $18.96 and the range of prices were between $18.96 and $19.9599. Upon request by the SEC staff, the Issuer, or any security holder of t…

Original filing · 0002048497-26-000018
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

BBNX